Effect of Hydroxymethylglutaryl-CoA Reductase Inhibitors on Low-density Lipoprotein Cholesterol, Interleukin-6, and High-Sensitivity C-Reactive Protein in End-stage Renal Disease. Iranian Journal of Kidney Diseases, [S. l.], v. 5, n. 1, p. 29–33, 2010. Disponível em: https://www.ijkd.org/index.php/ijkd/article/view/209.. Acesso em: 18 may. 2024.